In its phase 2 trial, retatrutide improved blood pressure, lipids, and glycemia as secondary endpoints, consistent with its weight effect though these are early, secondary findings in a relatively small study
Headaches are also relatively common
, leading to an uptick in patients getting diagnosed and starting prescriptions for other conditions, according to a new analysis by health-data firm Truveta
Thomas Kilkenny, DO, director of the Institute of Sleep Medicine, Pulmonary & Critical Care at Northwells Staten Island University Hospital, also spoke with MNT about the study
Yes, GLP-1 medications can interact with certain medications
Starting both simultaneously makes it difficult to determine which compound is causing any issues you experience